Controversies in primary treatment of low-risk papillary thyroid cancer.
about
What is the Minimal Surgery for Papillary Thyroid Carcinoma?Risk stratification of thyroid nodules on ultrasonography with the French TI-RADS: description and reflections.Managing newly diagnosed thyroid cancerProgress in molecular-based management of differentiated thyroid cancerThe BRAF(V600E) mutation in papillary thyroid microcarcinoma: does the mutation have an impact on clinical outcome?Extended Antitumor Response of a BRAF V600E Papillary Thyroid Carcinoma to VemurafenibRisk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma.Ultrasonography of thyroid nodules: a pictorial review.Thyroid incidentalomas: epidemiology, risk stratification with ultrasound and workup.Effects of siRNA on RET/PTC3 junction oncogene in papillary thyroid carcinoma: from molecular and cellular studies to preclinical investigationsSolitary lateral neck node metastasis in papillary thyroid carcinoma.Efficacy of Superselective Neck Dissection in Detecting Metastasis in Patients with cN0 Papillary Thyroid Carcinoma at High Risk of Lateral Neck Metastasis.Long-term treatment-related morbidity in differentiated thyroid cancer: a systematic review of the literatureEfficacy comparison of the anterior low small incision and the traditional incision for treatment of thyroid adenomaLong-term, treatment-free survival in select patients with distant metastatic papillary thyroid cancer.Association between BRAF V600E mutation and recurrence of papillary thyroid cancer.TLR3 correlated with cervical lymph node metastasis in patients with papillary thyroid cancer.The Usefulness of Preoperative Thyroid-Stimulating Hormone for Predicting Differentiated Thyroid Microcarcinoma.Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells.Total thyroidectomy as primary surgical management for thyroid disease: surgical therapy experience from 5559 thyroidectomies in a less-developed region.Practice patterns in the management of patients with differentiated thyroid cancer in Ontario Canada 2000-2008Tumor size interpretation for predicting cervical lymph node metastasis using a differentiated thyroid cancer risk modelSecond malignancies in patients with differentiated thyroid carcinoma treated with low and medium activities of radioactive I-131.Aberrantly methylated genes in human papillary thyroid cancer and their association with BRAF/RAS mutation.Stimulation of TLR4 by LMW-HA induces metastasis in human papillary thyroid carcinoma through CXCR7.Nodal recurrence in the lateral neck after total thyroidectomy with prophylactic central neck dissection for papillary thyroid cancer.Optimal differentiated thyroid cancer management in the elderly.The Effect of Thyroiditis on the Yield of Central Compartment Lymph Nodes in Patients with Papillary Thyroid Cancer.Effect of a second primary thyroid carcinoma on patients with head and neck squamous cell carcinoma.F-18 FDG-PET-CT in the Diagnostic of a Late Medullary Thyroid Carcinoma Recurrence in a Patient with Follicular-Papillary Thyroid Cancer.Surgical approach to level VI in papillary thyroid carcinoma: an overview.Lymph node metastasis characteristics of papillary thyroid carcinoma located in the isthmus: A single-center analysis.The impact of coexistent Hashimoto's thyroiditis on lymph node metastasis and prognosis in papillary thyroid microcarcinoma.Thyroid cancer after hysterectomy on benign indications: Findings from an observational cohort study in Sweden.Targeted next generation sequencing identifies somatic mutations and gene fusions in papillary thyroid carcinoma.Differentiated thyroid cancer in people aged 85 and older.Diagnostic, therapeutic and health-care management protocol in thyroid surgery: a position statement of the Italian Association of Endocrine Surgery Units (U.E.C. CLUB).New genomic somatic amplifications and deletions in papillary thyroid cancer.Aging-Related Disease Risks among Young Thyroid Cancer Survivors.Clonality analysis of multifocal papillary thyroid carcinoma by using genetic profiles.
P2860
Q26765080-3796B8CA-7A57-4B4F-8155-09AD37290D5CQ26795675-AB7F510A-4C0C-44E1-8CAF-57D86EB74263Q26825293-B234EF06-E146-47BE-B119-EC9334DBB15EQ26999887-2875327C-A895-47C0-80CE-52463FB04ADAQ27852737-32725D2D-A594-4F4B-A2C2-68A4B4268664Q27853034-49EAC0A9-060A-4A20-821E-EEE3E27C4464Q30374928-04443A7C-E506-4856-9471-5E71D07CE60DQ30391829-29A1A340-0286-4A23-8B91-4168A89A17E5Q30417649-E661CEA1-189A-4C06-BB35-66A08C8C0398Q31159590-BEC2D40D-22B2-4809-9C19-E5A8FDF0DEC8Q33593075-F8F18AB0-2176-4902-AC49-38C4B0328AA8Q33662263-A8D0E12D-AB13-4F96-91E5-3B061CEFC3EBQ33714084-1578DDF9-4D7E-4D70-AD1F-DFAA32B16175Q34176303-89215C88-0CCF-4A31-8948-52B64240D985Q34453011-31D01B82-161E-4EAA-8C5D-3908C3D43F01Q34716574-173D4DB9-4385-43A1-AF6C-76653E1A9111Q35017077-95A2C026-18C1-4ECB-AE91-85EFBE55C6D6Q35849441-337ADF39-F60E-410C-9994-5DEC660D7113Q35931194-DC7B414C-84A7-4BA0-A5B4-A9B178085681Q36489686-017B0265-78D1-4C62-9BA1-F9D1C230743FQ36561074-C27DB16C-50D7-42FB-9DA2-01B6F9FC35CDQ37187701-0E81DEDC-2EFB-499B-87E3-3D547981C475Q37187833-24E8E4DF-CBA1-4D76-A6EC-F3B6455E0AA4Q37365523-8026CF8E-D7A8-4E2A-8E28-222AE2E011B7Q37398442-83F37842-A1EB-4D52-A697-4B3D89EC1138Q37564130-6438F988-B072-4B0F-AC89-A9C3309F4C15Q38396892-0B30E3D8-265E-4172-8082-BE532C6ED03DQ38410316-DE106110-E0EB-46D9-AFCA-6EBE54725A19Q38474846-772A299D-A072-4FB3-BA84-7BA14825864BQ38515301-A2D6CCB5-E3D7-4D5B-A614-EA1E46A04795Q39371366-7BDBA721-E476-4BCD-8CFF-C59905399E01Q40160313-6117E718-E193-4E51-8E58-B45F6B17E664Q40183440-EF26647D-98A2-4A2B-BEE2-AF286D91F0C5Q40373182-03645F66-9788-46A2-9B09-E5953747D251Q41233717-CAABD908-4358-4B94-9190-E6058FB7EA69Q41758750-6F0C4D4C-6543-47E8-AE68-66CD58E6A5D9Q42688152-0DAD4ACB-AA14-4DA3-B0B0-82B2356D669CQ43198681-613AB023-31FD-4E4A-95D0-CC7978E52571Q46799892-91FE5E01-938B-4D1F-9144-7A3AC2C73074Q47093606-8EB8BD4E-F781-40F3-AD2F-D69D180A5096
P2860
Controversies in primary treatment of low-risk papillary thyroid cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Controversies in primary treatment of low-risk papillary thyroid cancer.
@ast
Controversies in primary treatment of low-risk papillary thyroid cancer.
@en
Controversies in primary treatment of low-risk papillary thyroid cancer.
@nl
type
label
Controversies in primary treatment of low-risk papillary thyroid cancer.
@ast
Controversies in primary treatment of low-risk papillary thyroid cancer.
@en
Controversies in primary treatment of low-risk papillary thyroid cancer.
@nl
prefLabel
Controversies in primary treatment of low-risk papillary thyroid cancer.
@ast
Controversies in primary treatment of low-risk papillary thyroid cancer.
@en
Controversies in primary treatment of low-risk papillary thyroid cancer.
@nl
P2093
P1433
P1476
Controversies in primary treatment of low-risk papillary thyroid cancer.
@en
P2093
Anna M Sawka
David S Cooper
Donald S A McLeod
P304
P356
10.1016/S0140-6736(12)62205-3
P407
P577
2013-03-22T00:00:00Z